Terrence Chew, M.D., R.A.C. has over 30 years of experience in the biotechnology and pharmaceutical industries, clinical medicine, and has served as a consultant to numerous biotechnology companies providing expert advice on clinical trials, drug development and regulatory processes.
Previously, he has held senior positions at Peregrine Pharmaceuticals, Agouron Pharmaceuticals, Argos Therapeutics, and ImmuneWorks where he managed the clinical and regulatory strategies. As a seasoned veteran Dr. Chew has been involved in the approval of five New Drug Applications with the US FDA, including marketed oncology drugs DaunoXome®, Taxotere® and DepoCyt®.
Dr. Chew earned his undergraduate degree in biochemistry from the University of California at Berkeley and his medical degree from the University of California in Los Angeles. Dr. Chew also holds a Regulatory Affairs Certification.